Clinical Trials

367 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06195189 2026-05-08

WU-KONG36

Phase 1/2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT06800339 2026-05-06

NEORADJUVANT

18 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07288034 2026-04-15

Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial

535 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07354061 2026-04-01

TD-ENSEMBLE

Phase 1/2 Recruiting

20 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06538038 2026-03-27

Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients

Recruiting

538 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05378334 2026-03-10

Efficacy and Safety of HGXJT in Bone Metastatic NSCLC Patients

82 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07452003 2026-03-05

An Exploratory Study of QL1706 Plus Chemotherapy in Perioperative NSCLC

Carcinoma, Non-Small-Cell Lung

NCT07408635 2026-02-13

IBI363 (PD-1/IL-2α-bias) in Combination With Chemotherapy as Neoadjuvant Therapy in Initially Unresectable Stage III Non-Small Cell Lung Cancer

43 enrolled

Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT04297605 2026-02-09

Study of Pembrolizumab and Single Agent Chemotherapy as First Line Treatment for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer With Eastern Cooperative Oncology Group (ECOG) Performance Status of 2

28 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04151940 2026-01-14

PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer

80 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07330596 2026-01-09

QL1706 Combined With Chemotherapy in the Treatment of Immune-mediated NSCLC

96 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06899126 2026-01-08

DESTINY-Lung06

Phase 3 Recruiting

686 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06877299 2026-01-02

Low-Dose Radiation + SBRT + Tislelizumab Plus Platinum-based Chemotherapy in Stage ⅡA-ⅢB Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06102057 2025-12-17

PACCELIO

110 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06652048 2025-11-21

High-dose Furmonertinib or Combined With Chemotherapy in EGFR-mutant Advanced NSCLC After Disease Progression on Third-generation EGFR-TKI

60 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06228326 2025-10-24

KYANITE-1

Phase 1/2 Recruiting

250 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

NCT06784791 2025-08-29

NEOpredict-EGF

20 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06896422 2025-08-07

Randomized Trial of Glutathione With Anti-PD-1 and Chemotherapy in Advanced NSCLC

80 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06709859 2025-07-17

Afatinib Combined With Chemotherapy as Conversion Therapy in Unresectable EGFR Sensitive Mutation-positive Stage III NSCLC

Carcinoma, Non-Small-Cell Lung

NCT07034391 2025-06-24

A Study Evaluating the Efficacy of PD-1 Inhibitor Combined With Denosumab and Chemotherapy in Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Patients With Driver Gene-Negative Status

Carcinoma, Non-Small-Cell Lung

NCT07016126 2025-06-11

D-BACE in Combination With Chemotherapy and Carelizumab for Resectable II-IIIA or Potentially Resectable T3-4N2 Stage IIIB NSCLC

Phase 3 Recruiting

70 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06598527 2025-05-29

SACTION2401

Phase 3 Recruiting

360 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05742607 2025-05-16

MATISSE

70 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06939127 2025-04-22

Cryoablation Combined With Tislelizumab and Chemotherapy as Neoadjuvant and Adjuvant Therapy in Resectable Stage II-IIIB NSCLC

38 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05255302 2025-04-01

DIAL

Phase 2/3 Recruiting

1,360 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06788366 2025-01-23

AI-HOPE Lung Cancer: Building a Predictive Tool for Metastatic Lung Cancer

Recruiting

2,000 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06718309 2024-12-05

Chemotherapy Plus Immunotherapy Combined With SBRT as Neoadjuvant Therapy for Patients With Resectable NSCLC

Carcinoma, Non-Small-Cell Lung

NCT05979818 2024-11-19

BRIO

6 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04322890 2024-10-22

PIKACHU

6,000 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06501378 2024-08-28

Cranial Radiotherapy Plus Chemoimmunotherapy in Untreated Driver-mutation Negative NSCLC With Active Brain Metastasis

Carcinoma, Non-Small-Cell Lung

NCT06501391 2024-08-28

Cranial Radiotherapy Plus Chemoimmunotherapy in Untreated Driver-mutation Negative NSCLC With Stable Brain Metastasis

54 enrolled

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT05059951 2024-06-04

CREATE

Recruiting

15,000 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05584267 2024-05-30

Immune Treatment of Brain Metastasis of Lung Cancer Combined With Large-segmentation Precision Radiotherapy

140 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06406608 2024-05-09

Patient-derived Organoid Drug Sensitivity Guided Treatment for Drug-resistant Recurrent Non-Small Cell Lung Cancer

20 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06241807 2024-02-14

Neoadjuvant Camrelizumab Combined With Chemotherapy for Resectable Stage IIIA-IIIB NSCLC

Carcinoma, Non-Small-Cell Lung

NCT04728724 2023-09-13

Neoadjuvant Immunotherapy for Stage III Non-small Cell Lung Cancer

100 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05940532 2023-07-11

A Trial of Sugemalimab and Chemotherapy in Unresectable Stage III NSCLC

41 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05913089 2023-06-29

A Clinical Study of TQB2450 Injection Combined With Chemotherapy or Anlotinib Hydrochloride Capsule in the Treatment of Non Small Cell Lung Cancer

58 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05351320 2022-04-28

WX-0593 Combined With Concurrent Chemoradiotherapy in Unresectable Locally Advanced NSCLC